Home » Topics » BioWorld Science

BioWorld Science
RSS

P53 upregulation predicts malaria immunity in children

Sep. 12, 2019

Phio Pharmaceuticals enters agreement with Carisma Therapeutics to enhance adoptive cell therapy

Sep. 12, 2019

KAHR Medical, Roche trial collaboration to test DSP-107/atezolizumab in lung cancer

Sep. 12, 2019

Girafpharma describes cyclin-dependent kinase inhibitors

Sep. 12, 2019

Memorial Sloan-Kettering Cancer Center patents anticancer agents

Sep. 12, 2019

New analgesics synthesized at Daiichi Sankyo

Sep. 12, 2019

Incyte presents new MAP4K1 inhibitors

Sep. 12, 2019

Gilead discloses new HIV replication inhibitors

Sep. 12, 2019

Transgenic CYP2C19 mouse as a new animal model for hyperdopaminergism-induced hyperkinesia

Sep. 12, 2019

NEK7 identified as potential biomarker associated with obsessive compulsive disorder

Sep. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...